NCT02383927 2024-07-11Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS MutationsKura Oncology, Inc.Phase 2 Completed63 enrolled 19 charts
NCT00005842 2013-02-11Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerNational Cancer Institute (NCI)Phase 1 Completed24 enrolled